Search research articles
Contact Us
Filters
Showing results (11-20 of 34) with videos related to
Page
of 4
Sort By:
Journal for Immunotherapy of Cancer
|
June 21, 2022
Antibody-based redirection of universal Fabrack-CAR T cells selectively kill antigen bearing tumor cells
Yi-Chiu Kuo, Cheng-Fu Kuo, Kurt Jenkins, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 5, 2014
Chimeric antigen receptors with mutated IgG4 Fc spacer avoid fc receptor binding and improve T cell persistence and antitumor efficacy
Mahesh Jonnalagadda, Armen Mardiros, Ryan Urak, et al.
Nano Letters
|
October 25, 2019
Massively-Parallelized, Deterministic Mechanoporation for Intracellular Delivery
Harish G Dixit, Renate Starr, Morgan L Dundon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 6, 2018
PET of Adoptively Transferred Chimeric Antigen Receptor T Cells with <sup>89</sup>Zr-Oxine
Michael R Weist, Renate Starr, Brenda Aguilar, et al.
JAMA Oncology
|
October 8, 2020
Systemic Anti-PD-1 Immunotherapy Results in PD-1 Blockade on T Cells in the Cerebrospinal Fluid
Jana Portnow, Dongrui Wang, M Suzette Blanchard, et al.
Cancer Immunology Research
|
March 21, 2019
IL15 Enhances CAR-T Cell Antitumor Activity by Reducing mTORC1 Activity and Preserving Their Stem Cell Memory Phenotype
Darya Alizadeh, Robyn A Wong, Xin Yang, et al.
Cancer Research Communications
|
March 27, 2023
Inclusion of 4-1BB Costimulation Enhances Selectivity and Functionality of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells
Renate Starr, Brenda Aguilar, Diana Gumber, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 8, 2022
Engineered IL13 variants direct specificity of IL13Rα2-targeted CAR T cell therapy
Lawrence A Stern, Sharareh Gholamin, Ignacio Moraga, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 7, 2017
Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma
Christine E Brown, Brenda Aguilar, Renate Starr, et al.
Blood
|
September 14, 2013
T cells expressing CD123-specific chimeric antigen receptors exhibit specific cytolytic effector functions and antitumor effects against human acute myeloid leukemia
Armen Mardiros, Cedric Dos Santos, Tinisha McDonald, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 34) with videos related to
Sort By:
Page
of 4
Journal for Immunotherapy of Cancer
|
June 21, 2022
Antibody-based redirection of universal Fabrack-CAR T cells selectively kill antigen bearing tumor cells
Yi-Chiu Kuo, Cheng-Fu Kuo, Kurt Jenkins, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 5, 2014
Chimeric antigen receptors with mutated IgG4 Fc spacer avoid fc receptor binding and improve T cell persistence and antitumor efficacy
Mahesh Jonnalagadda, Armen Mardiros, Ryan Urak, et al.
Nano Letters
|
October 25, 2019
Massively-Parallelized, Deterministic Mechanoporation for Intracellular Delivery
Harish G Dixit, Renate Starr, Morgan L Dundon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 6, 2018
PET of Adoptively Transferred Chimeric Antigen Receptor T Cells with <sup>89</sup>Zr-Oxine
Michael R Weist, Renate Starr, Brenda Aguilar, et al.
JAMA Oncology
|
October 8, 2020
Systemic Anti-PD-1 Immunotherapy Results in PD-1 Blockade on T Cells in the Cerebrospinal Fluid
Jana Portnow, Dongrui Wang, M Suzette Blanchard, et al.
Cancer Immunology Research
|
March 21, 2019
IL15 Enhances CAR-T Cell Antitumor Activity by Reducing mTORC1 Activity and Preserving Their Stem Cell Memory Phenotype
Darya Alizadeh, Robyn A Wong, Xin Yang, et al.
Cancer Research Communications
|
March 27, 2023
Inclusion of 4-1BB Costimulation Enhances Selectivity and Functionality of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells
Renate Starr, Brenda Aguilar, Diana Gumber, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 8, 2022
Engineered IL13 variants direct specificity of IL13Rα2-targeted CAR T cell therapy
Lawrence A Stern, Sharareh Gholamin, Ignacio Moraga, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 7, 2017
Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma
Christine E Brown, Brenda Aguilar, Renate Starr, et al.
Blood
|
September 14, 2013
T cells expressing CD123-specific chimeric antigen receptors exhibit specific cytolytic effector functions and antitumor effects against human acute myeloid leukemia
Armen Mardiros, Cedric Dos Santos, Tinisha McDonald, et al.
Page
of 4